PGLNext is a next generation sequencing panel that simultaneously analyzes 14 genes associated with an increased risk of developing paragangliomas (PGLs) and/or pheochromocytomas (PCCs). The testing can be considered at any age in the presence of PGL/PCC with a personal or family history of kidney, thyroid, breast cancer, neurofibromas, kidney, or gastrointestinal stromal tumors (GIST) on the same side of the family.
EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1), FH (Fumarate Hydratase), KIF1B (Kinesin Family Member 1B), MAX (MYC Associated Factor X), MEN1 (Menin 1), NF1 (Neurofibromin 1)
See More ...
Next-Generation Sequencing (NGS)